FBR Capital Initiates Biocryst Pharmaceuticals With Outperform By: Benzinga via Benzinga April 21, 2015 at 08:31 AM EDT Analysts at FBR Capital initiated coverage on Biocryst Pharmaceuticals, Inc. (NASDAQ: BCRX) with a Outperform rating. The target ... Read More >> Related Stocks: Biocryst Pharma Inc